Terminology Service for NFDI4Health
Gemcitabine Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C160043
A chemotherapy regimen consisting of gemcitabine that may be used in the treatment of bone, soft tissue, uterine and AIDS-related Kaposi sarcomas; bladder, breast, cervical, hepatobiliary, lung, ovarian, fallopian tube and primary peritoneal cancers; malignant pleural mesothelioma; pancreatic adenocarcinoma; and thymomas and thymic carcinomas. [ ]
Term info
Label
Gemcitabine Regimen
Synonyms
- Gemcitabine HCl Regimen
- Gemcitabine Hydrochloride Regimen
- Gemcitabine Regimen
- Gemzar Regimen
- Infugem Regimen
Subsets
NCIT_C160951, NCIT_C160950
Preferred Name
Gemcitabine Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C160043
Term relations
Subclass of:
- Regimen Used to Treat Malignant Thymus Neoplasm
- Regimen Used to Treat Hepatobiliary Cancer
- Regimen Used to Treat Breast Carcinoma
- Regimen Used to Treat Malignant Mesothelioma
- Regimen Used to Treat Bladder Carcinoma
- Regimen Used to Treat Malignant Ovarian Neoplasm
- Regimen Used to Treat Malignant Peritoneal Neoplasm
- Regimen Used to Treat Cervical Carcinoma
- Regimen Used to Treat Pancreatic Carcinoma
- Regimen Used to Treat Malignant Fallopian Tube Neoplasm
- Chemotherapy_Regimen_Has_Component some Gemcitabine Hydrochloride